Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Oct 11, 2022

BUY
$148.29 - $182.55 $122,190 - $150,421
824 Added 46.69%
2,589 $384,000
Q2 2022

Aug 10, 2022

BUY
$155.97 - $200.09 $1,871 - $2,401
12 Added 0.68%
1,765 $303,000
Q1 2022

Apr 06, 2022

BUY
$181.39 - $234.03 $12,153 - $15,680
67 Added 3.97%
1,753 $331,000
Q4 2021

Feb 01, 2022

BUY
$193.69 - $247.03 $17,044 - $21,738
88 Added 5.51%
1,686 $411,000
Q3 2021

Oct 27, 2021

BUY
$189.29 - $209.69 $27,636 - $30,614
146 Added 10.06%
1,598 $310,000
Q2 2021

Aug 09, 2021

BUY
$155.9 - $187.99 $226,366 - $272,961
1,452 New
1,452 $271,000
Q4 2020

Jan 28, 2021

SELL
$157.07 - $174.35 $1.12 Million - $1.24 Million
-7,119 Closed
0 $0
Q3 2020

Nov 02, 2020

SELL
$137.1 - $165.37 $1,508 - $1,819
-11 Reduced 0.15%
7,119 $1.16 Million
Q2 2020

Jul 17, 2020

SELL
$111.92 - $142.53 $559 - $712
-5 Reduced 0.07%
7,130 $978,000
Q1 2020

Jun 05, 2020

BUY
$92.66 - $144.94 $88,768 - $138,852
958 Added 15.51%
7,135 $995,000
Q4 2019

Jan 24, 2020

SELL
$116.25 - $133.25 $21,738 - $24,917
-187 Reduced 2.94%
6,177 $818,000
Q3 2019

Nov 12, 2019

BUY
$112.57 - $128.43 $2,476 - $2,825
22 Added 0.35%
6,364 $793,000
Q2 2019

Aug 09, 2019

SELL
$97.98 - $114.28 $8,524 - $9,942
-87 Reduced 1.35%
6,342 $714,000
Q1 2019

May 02, 2019

SELL
$81.56 - $100.67 $23,244 - $28,690
-285 Reduced 4.24%
6,429 $647,000
Q4 2018

Feb 06, 2019

SELL
$79.28 - $95.27 $399,095 - $479,589
-5,034 Reduced 42.85%
6,714 $574,000
Q3 2018

Oct 23, 2018

BUY
$83.5 - $93.23 $5,594 - $6,246
67 Added 0.57%
11,748 $1.08 Million
Q2 2018

Jul 31, 2018

BUY
$79.9 - $89.2 $933,311 - $1.04 Million
11,681 New
11,681 $995,000

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $82.8B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Telemus Capital, LLC Portfolio

Follow Telemus Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Telemus Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Telemus Capital, LLC with notifications on news.